Characterization of urinary metabolites from Sprague-Dawley rats and B6C3F1 mice exposed to [1,2,3,4-13C]butadiene

Chemical Research in Toxicology

Volumn 9, Issue 4, 1996, Pages 764-773

  Nauhaus, Sara K ^a,b   Fennell, Timothy R ^a   Asgharian, Bahman ^a   Bond, James A ^a   Sumner, Susan C J ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

1,3 BUTADIENE DERIVATIVE; ACROLEIN; ALDEHYDE; BUTADIENE DIEPOXIDE; CYSTEINE DERIVATIVE; DIHYDROXYACETONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; DETOXIFICATION; EPOXIDATION; GLUTATHIONE METABOLISM; MALE; METABOLITE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; URINARY EXCRETION;

ADMINISTRATION, INHALATION; ALDEHYDES; ANIMALS; BUTADIENES; CARBON ISOTOPES; CARCINOGENS; ENVIRONMENTAL EXPOSURE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MUTAGENS; OCCUPATIONAL EXPOSURE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0029973643     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx950196u     Document Type: Article

References (43)

1. Himmelstein, M. W., Acquavella, J. F., Recio, L., Medinsky, M. A., and Bond, J. A. (1995) Review of the toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol., in press.
2. Pelz, N., Dempster, A. M., and Shore, P. R. (1990) Analysis of low molecular weight hydrocarbons including 1,3-butadiene in engine exhaust gases using an aluminum oxide porous-layer opentubular fused-silica column. J. Chromatogr. Sci. 28, 230-235.
3. Brunnemann, K. D., Kagan, M. R., Cox, J. E., and Hoffmann, D. (1990) Analysis of 1,3-butadiene and other selected gas-phase components in cigarette mainstream and sidestream smoke by gas chromatography-mass selective detection. Carcinogenesis 11, 1863-1868.
4. EPA (1992) National emission standards for hazardous air pollutants for source categories; organic hazardous air pollutants from the synthetic organic chemical manufacturing industry and seven other processes. Fed. Regist. 57, 62608-62808.
5. de Meester, C. (1988) Genotoxic properties of 1,3-butadiene. Mutat. Res. 195, 273-281.
6. Cunningham, M. J., Choy, W. N., Arce, G. T., Rickard, L. B., Vlachos, D. A., Kinney, L. A., and Sariff, A. M. (1986) In Vivo sister chromatid exchange and micronucleus induction studies with 1,3-butadiene in B6C3F1 mice and Sprague-Dawley rats. Mutagenesis 1, 449-452.
7. Tice, R. R., Boucher, R., Luke, C. A., and Shelby, M. D. (1987) Comparative eytogenetic analysis of bone marrow damage induced in male B6C3F1 mice by multiple exposures to gaseous 1,3-butadiene. Environ. Mutagen. 9, 235-250.
8. Himmelstein, M. W., Asgharian, B., and Bond, J. A. (1995) High concentrations of butadiene epoxides in livers and lungs of mice compared to rats exposed to 1,3-butadiene. Toxicol. Appl. Pharmacol. 132, 281-288.
9. Himmelstein, M. W., Turner, M. J., Asgharian, B., and Bond, J. A. (1994) Comparison of blood concentrations of 1,3-butadiene and butadiene epoxides in mice and rats exposed to 1,3-butadiene by inhalation. Carcinogenesis 15, 1479-1486.
10. Thornton-Manning, J. R., Dahl, A. R., Bechtold, W. E., Griffith, W. C. J., and Henderson, R. F. (1995) Disposition of butadiene monoepoxide and butadiene diepoxide in various tissues of rats and mice following a low-level inhalation exposure to 1,3-butadiene. Carcinogenesis 16, 1723-1731.
11. Csanady, G. A., Guengerich, F. P., and Bond, J. A. (1992) Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. Carcinogenesis 13, 1143-1153.
12. Duescher, R. J., and Elfarra, A. A. (1994) Human liver microsomes are efficient catalysts for 1,3-butadiene oxidation: evidence for major roles by cytochrome P450 2A6 and 2E1. Arch. Biochem. Biophys. 311, 342-349.
13. Bond, J. A., Dahl, A. R., Henderson, R. F., Dutcher, J. S., Mauderly, J. L., and Birnbaum, L. S. (1986) Species differences in the disposition of inhaled butadiene. Toxicol. Appl. Pharmacol. 84, 617-627.
14. Dahl, A. R., Bechtold, W. E., Bond, J. A., Henderson, R. F., Mauderly, J. L., Muggenburg, B. A., Sun, J. D., and Birnbaum, L. S. (1990) Species differences in the metabolism and disposition of inhaled 1,3-butadiene and isoprene. Environ. Health Perspect. 86, 65-69.
15. Seaton, M. J., Follansbee, M. H., and Bond, J. A. (1995) Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes. Carcinogenesis 16, 2287-2293.
16. Duescher, R. J., and Elfarra, A. A. (1992) 1,3-Butadiene oxidation by human myeloperoxidase: role of chloride ion in catalysis of divergent pathways. J. Biol. Chem. 267, 19859-19865.
17. Maniglier-Poulet, C., Cheng, X., Ruth, J. A., and Ross, D. (1995) Metabolism of 1,3-butadiene to butadiene monoxide in mouse and human bone marrow cells. Chem.-Biol. Interact. 97, 119-129.
18. Cheng, X., and Ruth, J. A., (1993) A simplified methodology for quantitation of butadiene metabolites. Drug Metab. Dispos. 21, 121-124.
19. Elfarra, A. A., Duescher, R. J., and Pasch, C. M. (1991) Mechanisms of 1,3-butadiene oxidations to butadiene monoxide and crotonaldehyde by mouse liver microsomes and chloroperoxidase. Arch. Biochem. Biophys. 286, 244-251.
20. Sharer, J. E., Duescher, R. J., and Elfarra, A. A. (1992) Species and tissue differences in the microsomal oxidation of 1,3-butadiene and the glutathione conjugation of butadiene monoxide in mice and rats. Drug Metab. Dispos. 20, 658-664.
21. Sharer, J. E., and Elfarra, A. A. (1992) S-(2-Hydroxy-3-buten-1-yl)glutathione and S-(1-hydroxy-3-buten-2-yl)glutathione are in vivo metabolites of butadiene monoxide: detection and quantitation in bile. Chem. Res. Toxicol. 5, 787-790.
22. Elfarra, A. A., Sharer, J. E., and Duescher, R. J. (1995) Synthesis and characterization of N-acetyl-L-cysteine S-conjugates of butadiene monoxide and their detection and quantitation in urine of rats and mice given butadiene monoxide. Chem. Res. Toxicol. 8, 68-76.
23. Sabourin, P. J., Burka, L. T., Bechtold, W. E., Dahl, A. R., Hoover, M. D., Chang, I.-Y., and Henderson, R. F. (1992) Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene. Carcinogenesis 13, 1633-1638.
24. Bechtold, W. E., Strunk, M. R., Chang, I.-Y., Ward, J., and Henderson, R. R. (1994) Species differences in urinary butadiene metabolites: comparisons of metabolite ratios between mice, rats, and humans. Toxicol. Appl. Pharmacol. 127, 44-49.
25. Boogaard, P., Sumner, S. C. J., and Bond, J. A. (1996) Glutathione conjugation of 1,2:3,4-diepoxybutane in human rat and mouse liver and lung in vitro. Toxicol. Appl. Pharmacol. 136, 307-316.
26. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 5, 81-89.
27. 13C nuclear magnetic resonance spectroseopy. Chem. Res. Toxicol. 5, 553-560.
28. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 4, 678-687.
29. Sanduja, R., Ansari, G. A. S., and Boor, P. J. (1989) 3-Hydroxypropylmercapturic acid: A biologic marker of exposure to allylic and related compounds. J. Appl. Toxicol. 9, 235-238.
30. Ramu, K., Fraiser, L. H., Mamiya, B., Ahmed, T., and Kehrer, J. P. (1995) Acrolein mercapturates: synthesis, characterization and assessment of their role in the bladder toxicity of cyclophosphamide. Chem. Res. Toxicol. 8, 515-524.
31. 13C nuclear magnetic resonance spectroscopy. Drug Metab. Dispos. 20, 665-672.
32. Cannon, W. C., Blanton, E. F., and McDonald, K. E. (1983) The flow past chamber: an improved nose-only exposure system for rodents. Am. Ind. Hyg. Assoc. J. 44, 923-928.
33. Breitmaier, E., and Voelter, W. (1987) Carbon-13 NMR Spectroscopy, VCH, New York.
34. Nicholson, J. K., and Wilson, I. D. (1987) High resolution nuclear magnetic resonance spectroscopy of biological samples as an aid to drug development. Prog. Drug Res. 31, 427-479.
35. Osterman-Golkar, S., Kautiainen, A., Bergmark, E., Hakansson, K., and Maki-Paakkanen, J. (1991) Hemoglobin adducts and urinary mercapturic acids in rats as biological indicators of butadiene exposure. Chem-Biol. Interact. 80, 291-302.
36. Patel, J. M., Wood, J. C., and Leibman, K. C. (1980) The biotransformation of allyl alcohol and acrolein in rat liver and lung preparations. Drug Metab. Dispos. 8, 305-308.
37. Kaye, C. M. (1973) Biosynthesis of mercapturic acids from allyl alcohol, allyl esters and acrolein. Biochem. J. 134, 1093-1101.
38. Mitchell, D. Y., and Peterson, D. R. (1989) Metabolism of the glutathione-acrolein adduct, S-(2-aldehydo-ethyl)glutathione, by rat liver alcohol and aldehyde dehydrogenase. J. Pharmacol. Exp. Ther. 251, 193-198.
39. Draminski, W., Eder, E., and Henschler, D. (1983) A new pathway of acrolein metabolism in rats. Arch. Toxicol. 52, 243-247.
40. Gray, J. M., and Barnsley, E. A. (1971) The metabolism of crotyl phosphate, crotyl alcohol and crotonaldehyde. Xenobiotica 1, 55-67.
41. Saier, J. M. H. (1987) Enzymes in Metabolic Pathways: A comparative study of mechanism, structure, evolution, and control, Harper and Row, New York, NY.
42. Cochrane, J. E., and Skopek, T. R. (1994) Mutagenicity of butadiene and its epoxide metabolites. I. Mutagenic potential of 1,2-epoxybutene, 1,2,3,4-diepoxybutane and 3,4-epoxy-1,2-butane-diol in cultured human lymphoblasts. Carcinogenesis 15, 713-717.
43. Thier, R., Muller, M., Taylor, J. B., Pemble, S. E., Ketterer, B., and Guengerich, F. P. (1995) Enhancement of bacterial mutagenicity of bifunctional alkylating agents by expression of mammalian glutathione S-transferase. Chem. Res. Toxicol. 8, 465-472.